Related Experiment Video
Updated: Aug 8, 2026

Immunomagnetic Separation of Fat Depot-specific Sca1high Adipose-derived Stem Cells (ASCs)
Published on: August 11, 2016
Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma
1Department of Dermatology, Faculty of Medicine, University of Tokyo, Japan.
Insights
Serum levels of circulating intercellular adhesion molecule-1 (cICAM-1) were elevated in patients with localized scleroderma. Higher cICAM-1 levels correlated with disease severity and immune markers, suggesting immune activation in localized scleroderma.
Area of Science:
- Immunology
- Dermatology
- Rheumatology
Background:
- Intercellular adhesion molecule-1 (ICAM-1) plays a role in immune responses.
- Circulating ICAM-1 (cICAM-1) may indicate immune activation.
- Localized scleroderma exhibits immunologic abnormalities.
Purpose of the Study:
- To determine if serum cICAM-1 levels are elevated in localized scleroderma patients.
- To investigate correlations between cICAM-1 levels and clinical/serologic features of localized scleroderma.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to measure serum cICAM-1.
- Study included 48 patients with localized scleroderma, 20 with systemic sclerosis, and 20 healthy controls.
Main Results:
- Serum cICAM-1 levels were significantly higher in localized scleroderma patients compared to controls.
- Elevated cICAM-1 correlated with lesion count, affected areas, antihistone antibody IgM, and soluble interleukin 2 receptor.
Conclusions:
- Immune activation appears to be a contributing factor in localized scleroderma.
- cICAM-1 may serve as a biomarker for immune activity in localized scleroderma.
Background:
Intercellular adhesion molecule-1 (ICAM-1) is important in immune-mediated mechanisms, and its circulating form (cICAM-1) may be an indicator of immune activation. Localized scleroderma is accompanied by various immunologic abnormalities.
Objective:
We investigated whether the serum level of cICAM-1 in patients with localized scleroderma was elevated and was correlated with the clinical or serologic features of this disease.
Methods:
Serum cICAM-1 levels were determined by an enzyme-linked immunosorbent assay in 48 patients with localized scleroderma, in 20 patients with systemic sclerosis, and in 20 healthy control subjects.
Results:
Serum levels of cICAM-1 were significantly higher in patients with localized scleroderma than in the healthy control subjects. These levels correlated with the number of lesions, the number of involved areas, levels of antihistone antibody IgM, and levels of soluble interleukin 2 receptor.
Conclusion:
The results suggest that immune activation may be a factor in localized scleroderma.
Related Concept Videos
Overview of Cell-Matrix Interactions
Intracellular Signaling Affects Focal Adhesions
Some...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Atherosclerosis I: Introduction

